{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T12:19:12Z","timestamp":1791893952778,"version":"4.3.4"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/j.ejmech.2023.115181","type":"journal-article","created":{"date-parts":[[2023,2,4]],"date-time":"2023-02-04T02:02:27Z","timestamp":1675476147000},"page":"115181","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Discovery of unglycosylated indolocarbazoles as ROCK2 isoform-selective inhibitors for the treatment of breast cancer metastasis"],"prefix":"10.1016","volume":"250","author":[{"given":"Jinhui","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yijun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feihang","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yalin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanjing","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5825-5095","authenticated-orcid":false,"given":"Zhongjun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2023.115181_bib1","article-title":"3D microenvironment stiffness regulates tumor spheroid growth and mechanics via p21 and ROCK","volume":"3","author":"Taubenberger","year":"2019","journal-title":"Adv. Biosyst."},{"key":"10.1016\/j.ejmech.2023.115181_bib2","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/nrc1670","article-title":"Breast cancer metastasis: markers and models","volume":"5","author":"Weigelt","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejmech.2023.115181_bib3","doi-asserted-by":"crossref","first-page":"435","DOI":"10.7150\/thno.13896","article-title":"A pH-responsive host-guest nanosystem loading succinobucol suppresses lung metastasis of breast cancer","volume":"6","author":"Dan","year":"2016","journal-title":"Theranostics"},{"key":"10.1016\/j.ejmech.2023.115181_bib4","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1080\/15384047.2018.1456599","article-title":"Breast cancer lung metastasis: molecular biology and therapeutic implications","volume":"19","author":"Jin","year":"2018","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.ejmech.2023.115181_bib5","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s10238-016-0444-z","article-title":"Upregulation of ROCK2 in gastric cancer cell promotes tumor cell proliferation, metastasis and invasion","volume":"17","author":"Li","year":"2017","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.ejmech.2023.115181_bib6","doi-asserted-by":"crossref","first-page":"8742","DOI":"10.1158\/0008-5472.CAN-09-1541","article-title":"Inhibition of rho-associated kinase signaling prevents breast cancer metastasis to human bone","volume":"69","author":"Liu","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2023.115181_bib7","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s12272-019-01153-w","article-title":"Targeting ROCK\/LIMK\/cofilin signaling pathway in cancer","volume":"42","author":"Lee","year":"2019","journal-title":"Arch Pharm. Res. (Seoul)"},{"key":"10.1016\/j.ejmech.2023.115181_bib8","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1039\/C6MB00343E","article-title":"Discovery of a novel ROCK2 inhibitor with anti-migration effects via docking and high-content drug screening","volume":"12","author":"Chong","year":"2016","journal-title":"Mol. Biosyst."},{"key":"10.1016\/j.ejmech.2023.115181_bib9","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.1021\/acs.jmedchem.5b00308","article-title":"Design, synthesis, and biological evaluation of novel, highly active soft ROCK inhibitors","volume":"58","author":"Boland","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115181_bib10","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.ejmech.2019.06.089","article-title":"Potently inhibiting cancer cell migration with novel 3H-pyrazolo[4,3-f]quinoline boronic acid ROCK inhibitors","volume":"180","author":"Dayal","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115181_bib11","first-page":"134","article-title":"KD025 for patients with chronic graft-versus-host disease (cGVHD) - long-term follow-up of a phase 2a study (KD025-208)","author":"Jagasia","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.ejmech.2023.115181_bib12","doi-asserted-by":"crossref","first-page":"4777","DOI":"10.1158\/1078-0432.CCR-20-0700","article-title":"First-in-human study of AT13148, a dual ROCK-AKT inhibitor in patients with solid tumors","volume":"26","author":"McLeod","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejmech.2023.115181_bib13","doi-asserted-by":"crossref","first-page":"3321","DOI":"10.1158\/0008-5472.CAN-17-1339","article-title":"Rho kinase inhibition by AT13148 blocks pancreatic ductal adenocarcinoma invasion and tumor growth","volume":"78","author":"Rath","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2023.115181_bib14","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-14216-z","article-title":"ROCK inhibition with Fasudil induces beta-catenin nuclear translocation and inhibits cell migration of MDA-MB-231 human breast cancer cells","volume":"7","author":"Guerra","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejmech.2023.115181_bib15","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1021\/acs.jnatprod.7b01058","article-title":"Bioactive indolocarbazoles from the marine-derived streptomyces sp. DT-A61","volume":"81","author":"Wang","year":"2018","journal-title":"J. Nat. Prod."},{"key":"10.1016\/j.ejmech.2023.115181_bib16","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.phytol.2017.11.002","article-title":"Bioactive metabolites from marine-derived Streptomyces sp. A68 and its Rifampicin resistant mutant strain R-M1","volume":"23","author":"Qin","year":"2018","journal-title":"Phytochem. Lett."},{"key":"10.1016\/j.ejmech.2023.115181_bib17","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.bioorg.2018.09.016","article-title":"Bioactive staurosporine derivatives from the Streptomyces sp. NB-A13","volume":"82","author":"Zhou","year":"2019","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2023.115181_bib18","doi-asserted-by":"crossref","first-page":"12978","DOI":"10.1021\/acs.jmedchem.0c01271","article-title":"Identification, structure-activity relationships of marine-derived indolocarbazoles, and a dual PKC\u03b8\/\u03b4 inhibitor with potent antipancreatic cancer efficacy","volume":"63","author":"Wang","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115181_bib19","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.tet.2017.12.048","article-title":"Cytotoxic indolocarbazoles alkaloids from the Streptomyces sp. A65","volume":"74","author":"Zhou","year":"2018","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2023.115181_bib20","doi-asserted-by":"crossref","first-page":"281","DOI":"10.7164\/antibiotics.47.281","article-title":"MLR-52, (4'-demethylamino-4',5'-dihydroxystaurosporine), a new inhibitor of protein kinase C with immunosuppressive activity","volume":"47","author":"McAlpine","year":"1994","journal-title":"J. Antibiot. (Tokyo)"},{"key":"10.1016\/j.ejmech.2023.115181_bib21","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.7164\/antibiotics.39.1072","article-title":"The structures of the novel protein kinase C inhibitors K-252a, b, c and d","volume":"39","author":"Yasuzawa","year":"1986","journal-title":"J. Antibiot. (Tokyo)"},{"key":"10.1016\/j.ejmech.2023.115181_bib22","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1126\/science.1233606","article-title":"Monitoring drug target engagement in cells and tissues using the cellular thermal shift assay","volume":"341","author":"Molina","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.ejmech.2023.115181_bib23","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1021\/jm050540c","article-title":"Novel procedure for modeling ligand\/receptor induced fit effects","volume":"49","author":"Sherman","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115181_bib24","first-page":"680","article-title":"Understanding and overcoming tumor heterogeneity in metastatic breast cancer treatment","volume":"2","author":"Pasha","year":"2021","journal-title":"Nat. Can. (Que.)"},{"key":"10.1016\/j.ejmech.2023.115181_bib25","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.tem.2015.09.013","article-title":"Protein phosphorylation: a major switch mechanism for metabolic regulation","volume":"26","author":"Humphrey","year":"2015","journal-title":"Trends Endocrinol. Metabol."},{"key":"10.1016\/j.ejmech.2023.115181_bib26","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.tibs.2005.04.013","article-title":"Protein phosphorylation in signaling\u201350 years and counting","volume":"30","author":"Pawson","year":"2005","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.ejmech.2023.115181_bib27","doi-asserted-by":"crossref","first-page":"D607","DOI":"10.1093\/nar\/gky1131","article-title":"STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets","volume":"47","author":"Szklarczyk","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2023.115181_bib28","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res."},{"key":"10.1016\/j.ejmech.2023.115181_bib29","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.ccell.2019.10.002","article-title":"A potent and selective small-molecule degrader of STAT3 achieves complete tumor regression in vivo","volume":"36","author":"Bai","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ejmech.2023.115181_bib30","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/nrd4088","article-title":"Therapeutic modulators of STAT signalling for human diseases","volume":"12","author":"Miklossy","year":"2013","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2023.115181_bib31","doi-asserted-by":"crossref","first-page":"D956","DOI":"10.1093\/nar\/gkx1090","article-title":"LinkedOmics: analyzing multi-omics data within and across 32 cancer types","volume":"46","author":"Vasaikar","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmech.2023.115181_bib32","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1038\/onc.2014.72","article-title":"Drug-repositioning screening identified piperlongumine as a direct STAT3 inhibitor with potent activity against breast cancer","volume":"34","author":"Bharadwaj","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.ejmech.2023.115181_bib33","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/s41568-018-0090-8","article-title":"Therapeutically exploiting STAT3 activity in cancer - using tissue repair as a road map","volume":"19","author":"Huynh","year":"2019","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejmech.2023.115181_bib34","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1038\/s41388-018-0512-9","article-title":"The interaction of Lin28A\/Rho associated coiled-coil containing protein kinase2 accelerates the malignancy of ovarian cancer","volume":"38","author":"Zhong","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.ejmech.2023.115181_bib35","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ccr.2011.06.018","article-title":"ROCK and JAK1 signaling cooperate to control actomyosin contractility in tumor cells and stroma","volume":"20","author":"Sanz-Moreno","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ejmech.2023.115181_bib36","doi-asserted-by":"crossref","first-page":"2861","DOI":"10.1158\/0008-5472.CAN-04-2396","article-title":"Farnesyl transferase inhibitor (R115777)-induced inhibition of STAT3(Tyr705) phosphorylation in human pancreatic cancer cell lines require extracellular signal-regulated kinases","volume":"65","author":"Venkatasubbarao","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2023.115181_bib37","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.drudis.2013.09.010","article-title":"Advances in the development of Rho-associated protein kinase (ROCK) inhibitors","volume":"18","author":"Pan","year":"2013","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ejmech.2023.115181_bib38","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/978-3-030-35582-1_6","article-title":"Rho-ROCK signaling in normal physiology and as a key player in shaping the tumor microenvironment","volume":"1223","author":"Porazinski","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.ejmech.2023.115181_bib39","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1039\/B601930G","article-title":"Indolocarbazole natural products: occurrence, biosynthesis, and biological activity","volume":"23","author":"Sanchez","year":"2006","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.ejmech.2023.115181_bib40","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1039\/D0NP00096E","article-title":"The synthesis of biologically active indolocarbazole natural products","volume":"38","author":"Chambers","year":"2021","journal-title":"Nat. Prod. Rep."},{"key":"10.1016\/j.ejmech.2023.115181_bib41","doi-asserted-by":"crossref","first-page":"6642","DOI":"10.1021\/jm800986w","article-title":"Discovery of substituted 4-(pyrazol-4-yl)-phenylbenzodioxane-2-carboxamides as potent and highly selective Rho kinase (ROCK-II) inhibitors","volume":"51","author":"Feng","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115181_bib42","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1021\/jm400062r","article-title":"Synthesis and biological evaluation of urea derivatives as highly potent and selective Rho kinase inhibitors","volume":"56","author":"Yin","year":"2013","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115181_bib43","doi-asserted-by":"crossref","first-page":"5025","DOI":"10.1158\/0008-5472.CAN-12-0954","article-title":"RKI-1447 is a potent inhibitor of the Rho-associated ROCK kinases with anti-invasive and antitumor activities in breast cancer","volume":"72","author":"Patel","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2023.115181_bib44","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1158\/0008-5472.CAN-14-2156","article-title":"Rho kinase inhibitors block melanoma cell migration and inhibit metastasis","volume":"75","author":"Sadok","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejmech.2023.115181_bib45","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/nrclinonc.2018.8","article-title":"Targeting the IL-6\/JAK\/STAT3 signalling axis in cancer","volume":"15","author":"Johnson","year":"2018","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ejmech.2023.115181_bib46","doi-asserted-by":"crossref","first-page":"16814","DOI":"10.1073\/pnas.1414189111","article-title":"Selective oral ROCK2 inhibitor down-regulates IL-21 and IL-17 secretion in human T cells via STAT3-dependent mechanism","volume":"111","author":"Zanin-Zhorov","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.ejmech.2023.115181_bib47","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1182\/blood-2015-10-678706","article-title":"Targeted Rho-associated kinase 2 inhibition suppresses murine and human chronic GVHD through a STAT3-dependent mechanism","volume":"127","author":"Flynn","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.ejmech.2023.115181_bib48","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1038\/nn.3207","article-title":"Rho-kinase regulates energy balance by targeting hypothalamic leptin receptor signaling","volume":"15","author":"Huang","year":"2012","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.ejmech.2023.115181_bib49","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1021\/acs.jmedchem.5b00683","article-title":"Rho kinase (ROCK) inhibitors and their therapeutic potential","volume":"59","author":"Feng","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115181_bib50","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1016\/j.bmcl.2016.03.113","article-title":"A review on ROCK-II inhibitors: from molecular modelling to synthesis","volume":"26","author":"Shah","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2023.115181_bib51","doi-asserted-by":"crossref","first-page":"I","DOI":"10.1038\/nmeth1082","article-title":"HTRF (R) KinEASE (TM] TK: a new solution for tyrosine kinase screening","volume":"4","author":"Tardieu","year":"2007","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ejmech.2023.115181_bib52","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1038\/nprot.2006.179","article-title":"Sulforhodamine B colorimetric assay for cytotoxicity screening","volume":"1","author":"Vichai","year":"2006","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.ejmech.2023.115181_bib53","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1021\/acs.jnatprod.8b00544","article-title":"Medermycin-type naphthoquinones from the marine-derived Streptomyces sp. XMA39","volume":"81","author":"Jiang","year":"2018","journal-title":"J. Nat. Prod."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352342300096X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S022352342300096X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:47:48Z","timestamp":1759330068000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S022352342300096X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3]]},"references-count":53,"alternative-id":["S022352342300096X"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2023.115181","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of unglycosylated indolocarbazoles as ROCK2 isoform-selective inhibitors for the treatment of breast cancer metastasis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2023.115181","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115181"}}